GlassScriptPhysician profile
Victoria Starr
NPI 1609360718
$432.02
in general payments reported to CMS, 2019-2025
10 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.31 · 2023: $48.36 · 2024: $161 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.71 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $133.36 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $100.17 | 2024-2025 | Myfembree |
| Abbvie INC. | $56.40 | 2021-2023 | Lo Loestrin Fe |
| Merck Sharp & Dohme LLC | $39.77 | 2023-2024 | Gardasil 9, Gardasil, Rotateq |
| Exeltis, USA INC. | $20.46 | 2024 | Slynd |
| Intuitive Surgical, INC. | $19.00 | 2025 | |
| Organon LLC | $17.36 | 2024 | |
| Ironshore Pharmaceuticals INC. | $15.79 | 2024 | |
| Daiichi Sankyo INC. | $15.67 | 2024 | Injectafer |
| Mayne Pharma Commercial LLC | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Starr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.